phase readout
saveNCT07147101: Different First-line Immunotherapy for Advancer Hepatocellular Carcinoma: A Prospective Observational Study on Efficacy and Immune Microenvironment
RECRUITINGupdated 19d ago
community read0 votes
Sponsor: Fudan University. Phase: . Conditions: Advanced Hepatocellular Carcinoma (HCC)
view source ↗
comments(0)
5-min edit window · permanent after that